Britta Landin

733 total citations
31 papers, 514 citations indexed

About

Britta Landin is a scholar working on Genetics, Cell Biology and Spectroscopy. According to data from OpenAlex, Britta Landin has authored 31 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 13 papers in Cell Biology and 9 papers in Spectroscopy. Recurrent topics in Britta Landin's work include Hemoglobinopathies and Related Disorders (13 papers), Hemoglobin structure and function (12 papers) and Mass Spectrometry Techniques and Applications (8 papers). Britta Landin is often cited by papers focused on Hemoglobinopathies and Related Disorders (13 papers), Hemoglobin structure and function (12 papers) and Mass Spectrometry Techniques and Applications (8 papers). Britta Landin collaborates with scholars based in Sweden, Canada and United Kingdom. Britta Landin's co-authors include Michael C. Schotz, Gunvor Alvélius, K. Dilip, William J. Griffiths, Jer-Shung Twu, Å. Nilsson, Åke Nilsson, Å Nilsson, Brian N. Green and Elmo Jensen and has published in prestigious journals such as Analytical Chemistry, Journal of Lipid Research and European Journal of Biochemistry.

In The Last Decade

Britta Landin

30 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Britta Landin Sweden 13 190 119 110 92 84 31 514
Nora Anderson United States 5 265 1.4× 36 0.3× 56 0.5× 63 0.7× 94 1.1× 8 601
M A Orchard United Kingdom 13 205 1.1× 31 0.3× 33 0.3× 38 0.4× 61 0.7× 36 606
Shigeo Okubo Japan 17 455 2.4× 24 0.2× 70 0.6× 143 1.6× 52 0.6× 42 770
Arno van Rooij Netherlands 12 398 2.1× 48 0.4× 50 0.5× 17 0.2× 21 0.3× 16 630
Alessia Francesca Mozzi Italy 9 184 1.0× 31 0.3× 41 0.4× 16 0.2× 42 0.5× 12 476
John D. Vavra United States 5 267 1.4× 46 0.4× 156 1.4× 46 0.5× 19 0.2× 6 558
Kinya Koizumi Japan 11 215 1.1× 22 0.2× 51 0.5× 36 0.4× 30 0.4× 26 410
Arthur S. Brecher United States 14 181 1.0× 21 0.2× 43 0.4× 28 0.3× 74 0.9× 65 539
Cornelia M.M. van der Kruijssen Netherlands 14 315 1.7× 35 0.3× 63 0.6× 14 0.2× 37 0.4× 17 1.0k
Naoaki Murao Japan 15 205 1.1× 68 0.6× 8 0.1× 26 0.3× 59 0.7× 26 624

Countries citing papers authored by Britta Landin

Since Specialization
Citations

This map shows the geographic impact of Britta Landin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Landin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Landin more than expected).

Fields of papers citing papers by Britta Landin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Landin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Landin. The network helps show where Britta Landin may publish in the future.

Co-authorship network of co-authors of Britta Landin

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Landin. A scholar is included among the top collaborators of Britta Landin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Landin. Britta Landin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landin, Britta, Christin Sisowath, & Annelie Strålfors. (2023). Factors affecting the evaluation and use of a hemoglobin A2 method – Lot-to-lot variation, long-term deviation and carry-over. Clinica Chimica Acta. 544. 117332–117332. 1 indexed citations
2.
Tybring, Gunnel, et al.. (2016). Metabolomic Quality Assessment of EDTA Plasma and Serum Samples. Biopreservation and Biobanking. 14(5). 416–423. 24 indexed citations
3.
Dilip, K., Brian N. Green, Britta Landin, Gunvor Alvélius, & William J. Griffiths. (2004). Accurate mass measurement and tandem mass spectrometry of intact globin chains identify the low proportion variant hemoglobin Lepore–Boston–Washington from the blood of a heterozygote. Journal of Mass Spectrometry. 39(3). 289–294. 11 indexed citations
4.
Dilip, K., Gunvor Alvélius, & Britta Landin. (2002). IDENTIFICATION OF Hb KENYA (Aγ81Leu-β86Ala) BY ELECTROSPRAY MASS SPECTROMETRY. Hemoglobin. 26(1). 71–75. 6 indexed citations
5.
Bäcklund, L.B., Håkan Garpenstrand, Jonas Ekblom, et al.. (2001). Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus. Journal of Diabetes and its Complications. 15(5). 250–256. 37 indexed citations
6.
Dilip, K., William J. Griffiths, Gunvor Alvélius, & Britta Landin. (2001). Electrospray Mass Spectrometry: An Efficient Method to Detect Silent Hemoglobin Variants Causing Erythrocytosis. Clinical Chemistry. 47(7). 1308–1311. 10 indexed citations
7.
Dilip, K., Gunvor Alvélius, Britta Landin, & William J. Griffiths. (2000). Electrospray tandem mass spectrometry in the rapid identification of ?-chain haemoglobin variants. Rapid Communications in Mass Spectrometry. 14(14). 1184–1194. 14 indexed citations
8.
Qi, Zhongquan, Sven Björkman, Öyvind Östraat, et al.. (1996). Bioavailability of cyclosporine in rats after intragastric administration: a comparative study of the L2-phase and two other lipid-based vehicles. Transplant Immunology. 4(4). 313–317. 11 indexed citations
9.
Landin, Britta, et al.. (1995). Initiation codon mutation (ATG → ATA) of the β‐globin gene causing β‐thalassemia in a Swedish family. American Journal of Hematology. 48(3). 158–162. 9 indexed citations
10.
Landin, Britta & Anke van den Berg. (1994). α2-Globin Gene Mutation Hb G-Waimanalo: Occurrence in Combination with α-Thalassemia-1. Hemoglobin. 18(1). 71–72.
11.
Landin, Britta, et al.. (1994). Haemoglobin Köln as de novo mutations in Sweden: Diagnosis by PCR and specific enzymatic cleavage. European Journal Of Haematology. 52(3). 156–161. 3 indexed citations
12.
Landin, Britta, et al.. (1993). Rare β Chain Hemoglobin Variants Found in Swedish Patients During HBA1cAnalysis. Hemoglobin. 17(4). 303–318. 32 indexed citations
13.
Landin, Britta & Maria Åström. (1993). Unstable haemoglobin causing haemolytic anaemia: de novo mutation in Sweden identified by PCR. Journal of Internal Medicine. 233(3). 299–302. 2 indexed citations
14.
Landin, Britta. (1993). HB Karlskoga or α2β221(B3) ASP→HIS: A new Slow-Moving Variant Found in Sweden. Hemoglobin. 17(3). 201–208. 8 indexed citations
15.
Nilsson, Åke, Britta Landin, & Bengt Johansson. (1988). Plasma apolipoprotein A-I levels and bile lipid secretion during thoracic duct drainage in the rat. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 963(2). 231–236. 5 indexed citations
16.
Nilsson, Åke & Britta Landin. (1988). Metabolism of chylomicron arachidonic and linoleic acid in the rat. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 959(3). 288–295. 18 indexed citations
17.
Nilsson, Å, Britta Landin, & Michael C. Schotz. (1987). Hydrolysis of chylomicron arachidonate and linoleate ester bonds by lipoprotein lipase and hepatic lipase. Journal of Lipid Research. 28(5). 510–517. 44 indexed citations
18.
Landin, Britta, et al.. (1985). Efficient Hepatic Uptake of Chylomicron Remnant Cholesterol in Rats with a Portacaval Anastomosis. Scandinavian Journal of Gastroenterology. 20(3). 272–278. 3 indexed citations
19.
Landin, Britta, et al.. (1985). Rat α1‐microglobulin. European Journal of Biochemistry. 146(2). 353–358. 28 indexed citations
20.
Landin, Britta & Åke Nilsson. (1984). Metabolism of chylomicron phosphatidylethanolamine in the rat. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 793(1). 105–113. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026